Conmed (CNMD) Misses Q1 EPS by 21c, provides guidance

Conmed (NYSE: CNMD) reported Q1 EPS of $0.79, $0.21 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $321.3 million versus the consensus estimate of $332.91 million.

GUIDANCE:

Conmed sees FY2025 EPS of $4.45-$4.60, versus the consensus of $4.34. Conmed sees FY2025 revenue of $1.35-1.378 billion, versus the consensus of $1.357 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Dell (DELL) PT Raised to $735 at Melius
• Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance